Symbols

ASTH

Astrana Health·NASDAQ

--(--)

ASTH fundamentals

ASTH Q4 2025 Earnings

Astrana Health (ASTH) released its earnings on Mar 2, 2026: revenue was 950.53M (YoY +42.89%), beat estimates; EPS was 0.12 (YoY +180.00%), beat estimates.

Revenue / YoY

950.53M

+42.89%

EPS / YoY

0.12

+180.00%

Report date

Mar 2, 2026

ASTH Earnings Call Summary for Q4,2025

Record Growth: 2025 revenue up 56% to $3.2B, EBITDA $205M, free cash flow $104.5M. Q4 revenue $950M (43% YoY), EBITDA $52.5M (50% YoY).
Full-Risk Expansion: 80% of revenue in full-risk by Q1 2026, with Southern Nevada MLR improving 20%.
Prospect Synergies: $12-$15M annualized, 97% PCP retention, AI automating 2/3 of prior auths.
2026 Outlook: EBITDA $250-$280M (24% growth), free cash flow $105-$132.5M. Medicare Advantage rates expected to offset Medicaid headwinds.
AI Efficiency: G&A margin down 110bps to 6.8%, with further reductions via automation.

Earnings

EPS

Revenue

Revenue & Expenses

ASTH has released its 2025 Q4 earnings report, with revenue of 950.53M, reflecting a YoY change of 42.89%, and net profit of 6.56M, showing a YoY change of 184.38%. The Sankey diagram below clearly presents ASTH's revenue sources and cost distribution.

Key Indicators

Astrana Health (ASTH) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Astrana Health (ASTH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Astrana Health (ASTH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Astrana Health (ASTH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown